Related Experiment Video
Updated: Dec 6, 2025

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
Published on: April 9, 2019
Invasive aspergillosis complication in yellow fever vaccine induced viscerotropic disease
Giovanni Luis Breda1, Natália Ramos Domino1, Lucia de Noronha1
1Complexo Hospital de Clínicas, Universidade Federal Do Paraná, 180 General Carneiro Street, Curitiba, 80060-900, Brazil.
Abstract:
Invasive aspergillosis (IA) usually occurs in immunocompromised hosts, but in the last decade IA has emerged in critically ill non-neutropenic patients, as those with severe Influenza and Chronic Obstructive Pulmonary Disease (COPD). We report an unusual fatal case of disseminated IA in a non-immunocompromised patient following yellow fever vaccine-associated viscerotropic disease.
More Related Videos
10:01Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
07:06A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
Related Concept Videos
Cross-reactivity
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Fungal Phylum Ascomycota
Vaccinations
Allergic Drug Reactions